Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 8
2005 4
2006 5
2007 3
2008 4
2009 6
2010 7
2011 9
2012 6
2013 7
2014 12
2015 9
2016 11
2017 10
2018 10
2019 17
2020 8
2021 2
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary alveolar proteinosis.
Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, Wang T, Morgan C, Cottin V, McCarthy C. Trapnell BC, et al. Among authors: nakata k. Nat Rev Dis Primers. 2019 Mar 7;5(1):16. doi: 10.1038/s41572-019-0066-3. Nat Rev Dis Primers. 2019. PMID: 30846703 Review.
Pulmonary alveolar proteinosis.
Trapnell BC, Whitsett JA, Nakata K. Trapnell BC, et al. Among authors: nakata k. N Engl J Med. 2003 Dec 25;349(26):2527-39. doi: 10.1056/NEJMra023226. N Engl J Med. 2003. PMID: 14695413 Review. No abstract available.
Pulmonary alveolar proteinosis.
Presneill JJ, Nakata K, Inoue Y, Seymour JF. Presneill JJ, et al. Among authors: nakata k. Clin Chest Med. 2004 Sep;25(3):593-613, viii. doi: 10.1016/j.ccm.2004.04.002. Clin Chest Med. 2004. PMID: 15331195 Review.
Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF).
Masuki H, Okudera T, Watanebe T, Suzuki M, Nishiyama K, Okudera H, Nakata K, Uematsu K, Su CY, Kawase T. Masuki H, et al. Among authors: nakata k. Int J Implant Dent. 2016 Dec;2(1):19. doi: 10.1186/s40729-016-0052-4. Epub 2016 Aug 22. Int J Implant Dent. 2016. PMID: 27747711 Free PMC article.
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Oda M, Ishii H, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Sakagami T, Hashimoto A, Tanaka T, Takada T, Mikami A, Kitamura N, Nakata K. Tazawa R, et al. Among authors: nakata k. N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216. N Engl J Med. 2019. PMID: 31483963 Clinical Trial.
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
Trapnell BC, Inoue Y, Bonella F, Morgan C, Jouneau S, Bendstrup E, Campo I, Papiris SA, Yamaguchi E, Cetinkaya E, Ilkovich MM, Kramer MR, Veltkamp M, Kreuter M, Baba T, Ganslandt C, Tarnow I, Waterer G, Jouhikainen T; IMPALA Trial Investigators. Trapnell BC, et al. N Engl J Med. 2020 Oct 22;383(17):1635-1644. doi: 10.1056/NEJMoa1913590. Epub 2020 Sep 7. N Engl J Med. 2020. PMID: 32897035 Free PMC article. Clinical Trial.
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. Reply.
Tazawa R, Kitamura N, Nakata K. Tazawa R, et al. Among authors: nakata k. N Engl J Med. 2020 Jan 9;382(2):198. doi: 10.1056/NEJMc1914606. N Engl J Med. 2020. PMID: 31914250 No abstract available.
Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.
Saraya T, Kurai D, Nakagaki K, Sasaki Y, Niwa S, Tsukagoshi H, Nunokawa H, Ohkuma K, Tsujimoto N, Hirao S, Wada H, Ishii H, Nakata K, Kimura H, Kozawa K, Takizawa H, Goto H. Saraya T, et al. Among authors: nakata k. Front Microbiol. 2014 Aug 11;5:410. doi: 10.3389/fmicb.2014.00410. eCollection 2014. Front Microbiol. 2014. PMID: 25157244 Free PMC article. Review.
136 results